Skip to main content

Table 5 Summary of clinical chemistry data; mean (SD), N = 8

From: Safety evaluation of the interchangeable use of robenacoxib (Onsior™) tablets and solution for injection in dogs

Variable

(reference range and units) a

Day

Group 1

Group 2

Group 3

Group 4

P value

Treatment

Time

Alanine aminotransferase

(23.0–64.6 U/L)

−17

20.88

(7.12)

21.88

(4.91)

18.75

(4.65)

21.75

(5.01)

0.7693

<0.0001

−11

21.75

(4.23)

22.00

(3.78)

21.00

(3.82)

24.38

(7.11)

  

21

25.50

(6.00)

26.50

(4.28)

24.13

(4.36)

26.88

(5.36)

  

55

28.50

(6.44)

29.25

(4.95)

27.63

(5.21)

29.50

(6.09)

  

89

32.00

(7.84)

31.13

(4.67)

29.50

(4.14)

31.13

(5.84)

  

Aspartate aminotransferase

(28.1–59.7 U/L)

−17

29.00

(5.04)

30.25

(4.06)

28.25

(4.27)

30.63

(2.97)

0.5585

0.0002

−11

30.88

(3.68)

30.63

(3.46)

29.88

(2.85)

32.25

(4.46)

  

21

28.50

(3.74)

29.75

(2.60)

29.63

(3.74)

30.25

(4.62)

  

55

28.75

(3.24)

31.38

(4.50)

30.38

(6.23)

32.00

(5.50)

  

89

31.50

(5.86)

33.00

(4.07)

32.88

(3.44)

34.38

(5.04)

  

Alkaline phosphatase

(65.4–177.5 U/L)

−17

118.88

(22.90)

109.00

(30.81)

139.13

(32.89)

117.25

(23.92)

0.8396

<0.0001

−11

126.88

(27.03)

114.88

(32.42)

146.63

(33.43)

120.00

(25.60)

  

21

92.88

(19.98)

86.00

(25.47)

104.50

(29.08)

88.50

(22.77)

  

55

80.13

(15.63)

75.13

(17.31)

89.13

(25.05)

76.25

(19.77)

  

89

62.75

(13.47)

56.38

(13.41)

73.63

(22.92)

59.13

(15.82)

  

Urea nitrogen

(10.0–22.0 mg/dL)

−17

10.25

(2.25)

10.75

(1.28)

9.75

(1.49)

10.38

(1.60)

0.0196

0.0823

−11

12.00

(1.93)

11.50

(1.69)

11.00

(1.31)

12.38

(2.07)

  

21

16.00

(1.77)

15.50

(1.07)

13.13

(2.10)

14.50

(2.20)

  

55

16.00

(2.56)

17.13

(1.96)

14.75

(2.25)

14.88

(2.10)

  

89

16.63

(2.62)

16.38

(2.39)

14.25

(2.25)

14.63

(1.69)

  

Creatinine

(0.7–1.1 mg/dL)

−17

0.61

(0.06)

0.56

(0.05)

0.60

(0.08)

0.60

(0.05)

0.9290

<0.0001

−11

0.60

(0.08)

0.59

(0.04)

0.59

(0.06)

0.59

(0.06)

  

21

0.79

(0.06)

0.78

(0.05)

0.78

(0.07)

0.81

(0.04)

  

55

0.95

(0.09)

0.94

(0.07)

0.90

(0.09)

0.93

(0.09)

  

89

1.00

(0.05)

1.00

(0.09)

0.99

(0.08)

0.98

(0.07)

  

Total protein

(5.3–6.4 g/dL)

−17

4.75

(0.15)

4.71

(0.14)

4.84

(0.32)

4.91

(0.20)

0.4983

<0.0001

−11

4.71

(0.15)

4.74

(0.18)

4.85

(0.24)

4.80

(0.14)

  

21

4.98

(0.07)

4.99

(0.16)

5.09

(0.28)

5.11

(0.15)

  

55

5.23

(0.13)

5.24

(0.09)

5.35

(0.19)

5.36

(0.23)

  

89

5.10

(0.15)

5.25

(0.16)

5.36

(0.20)

5.24

(0.32)

  

Albumin

(2.9–3.9 g/dL)

−17

3.26

(0.15)

3.23

(0.10)

3.29

(0.19)

3.36

(0.18)

0.9691

0.1652

−11

3.25

(0.14)

3.20

(0.09)

3.30

(0.19)

3.29

(0.12)

  

21

3.50

(0.09)

3.44

(0.13)

3.55

(0.12)

3.54

(0.15)

  

55

3.51

(0.15)

3.51

(0.19)

3.48

(0.16)

3.55

(0.15)

  

89

3.53

(0.10)

3.54

(0.13)

3.64

(0.14)

3.53

(0.20)

  

Creatine kinase

(127.5–869.4 U/L)

−17

365.38

(57.30)

359.38

(80.96)

342.75

(22.22)

417.88

(96.99)

0.6395

0.2253

−11

318.38

(50.07)

322.88

(57.31)

324.75

(38.87)

403.50

(91.48)

  

21

240.88

(46.46)

289.75

(66.14)

277.88

(60.09)

336.25

(170.44)

  

55

223.25

(60.46)

248.13

(57.50)

254.00

(48.67)

302.38

(96.44)

  

89

270.00

(148.55)

255.50

(65.44)

314.38

(134.62)

285.88

(52.55)

  
  1. a These reference ranges have been derived from healthy young mongrel dogs (n = 124) and have been provided by the animal supplier. They are to be used for information only and the two values collected before the dosing period (at Day −17 and −11) should be used for interpretation in the context of this study